Research Seminars & Events
The Lerner emphasizes translational research that has the potential to improve patient care. Our scientists work closely with Cleveland Clinic physicians to transform groundbreaking discoveries made in the laboratory to the bedside. Our collaborative Research Centers of Excellence bring together scientific and clinical experts to solve problems seen in patients and accelerate discoveries into new treatments and cures.
July 2019 4
Title: "The application of regenerative medicine for the novel treatment approach of inflammatory bowel disease: safety, efficacy, and implications for disease discovery"
Amy Lightner, MD, Joint Appointment seminar
Title: "Th17 cell differentiation and function in mouse and human"
Mandy McGeachy, PhD, University of Pittsburgh School of Medicine. Invited by Xiaoxia Li, PhD.
Title: Ifit2, an interferon-induced protein, attenuates neuropathy in coronavirus-infected mice by promoting microglial activation and leukocyte migration to the central nervous system
Jayasri Das Sarma, PhD
Location: JJ3-107 1&2
Title: Identification of a Type 2 Diabetes Subtype Responsive to Intensive Glycemia Treatment
Daniel Rotroff, PhD, Assistant Staff, Department of Quantitative Health Sciences
We use a wide-range of computational and experimental approaches to leverage -omics technologies and electronic health records (EHR) to investigate many aspects of precision medicine, such as biomarker or risk allele discovery for drug response and disease outcomes. As a KL2 Scholar, we have funding to develop methods that utilize genomic and clinical data to identify high-risk subtypes within type 2 diabetes.